ACEY RX LLC
- CRANBURY, NJ 08512-3613
- ndcdrug.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $659.8K
- Awards on record
- 7
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
ACEY RX LLC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About ACEY RX LLC
- Headquarters
- CRANBURY, NJ 08512-3613
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIGUKFNKWGZLL1
- CAGE9YT15
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $659.8K
- Awards on record
- 7
- Top funding agencies
- Department of Veterans Affairs
Awards
36C77026P0116
Completed: Period of performance ended Nov 2, 2026EO 14398 DARUNAVIR 800MG TAB 30CT
Department of Veterans Affairs
- Obligated
- $39.3K
- Period of performance
- Aug 10, 2026 – Nov 2, 2026
36C77026P0044
Completed: Period of performance ended Mar 4, 2026COLESTIPOL HCL 1GM TAB 120CT BT (C0609)
Department of Veterans Affairs
- Obligated
- $66.5K
- Period of performance
- Feb 18, 2026 – Mar 4, 2026
36C77025P0246
Completed: Period of performance ended Nov 5, 2025CLINDAMYCIN PO4 1%
Department of Veterans Affairs
- Obligated
- $81.9K
- Period of performance
- Sep 5, 2025 – Nov 5, 2025
36C77025P0227
Completed: Period of performance ended Oct 21, 2025NATIONAL ORDER-MULTIPLE CMOP LOCATIONS WITHIN USA. SEVEN CLINS PHARMA
Department of Veterans Affairs
- Obligated
- $376.3K
- Period of performance
- Jul 21, 2025 – Oct 21, 2025
36C77025P0145
Completed: Period of performance ended May 5, 2025PHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $23.3K
- Period of performance
- Apr 25, 2025 – May 5, 2025
36C77025P0127
Completed: Period of performance ended Apr 22, 2025PHARMACEUTICALS F0355 FENOFIBRATE 145MG TAB (VA-25-00045945) 02-28-2025
Department of Veterans Affairs
- Obligated
- $47.4K
- Period of performance
- Apr 8, 2025 – Apr 22, 2025
36C77025P0078
Completed: Period of performance ended Feb 3, 2025PHARMACEUTICAL-6 LINE ITEMS-CLINDAMYCIN PO4 1% TOP SWAB 60CT, C0820-NDC: 45802-0263-37 FOR MULTISITE DELIVERY.
Department of Veterans Affairs
- Obligated
- $25.1K
- Period of performance
- Jan 23, 2025 – Feb 3, 2025
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
36C77026P0116 EO 14398 DARUNAVIR 800MG TAB 30CT | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $39.3K | Aug 10, 2026 – Nov 2, 2026 | Completed: Period of performance ended Nov 2, 2026 |
36C77026P0044 COLESTIPOL HCL 1GM TAB 120CT BT (C0609) | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $66.5K | Feb 18, 2026 – Mar 4, 2026 | Completed: Period of performance ended Mar 4, 2026 |
36C77025P0246 CLINDAMYCIN PO4 1% | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $81.9K | Sep 5, 2025 – Nov 5, 2025 | Completed: Period of performance ended Nov 5, 2025 |
36C77025P0227 NATIONAL ORDER-MULTIPLE CMOP LOCATIONS WITHIN USA. SEVEN CLINS PHARMA | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $376.3K | Jul 21, 2025 – Oct 21, 2025 | Completed: Period of performance ended Oct 21, 2025 |
36C77025P0145 PHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $23.3K | Apr 25, 2025 – May 5, 2025 | Completed: Period of performance ended May 5, 2025 |
36C77025P0127 PHARMACEUTICALS F0355 FENOFIBRATE 145MG TAB (VA-25-00045945) 02-28-2025 | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $47.4K | Apr 8, 2025 – Apr 22, 2025 | Completed: Period of performance ended Apr 22, 2025 |
36C77025P0078 PHARMACEUTICAL-6 LINE ITEMS-CLINDAMYCIN PO4 1% TOP SWAB 60CT, C0820-NDC: 45802-0263-37 FOR MULTISITE DELIVERY. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $25.1K | Jan 23, 2025 – Feb 3, 2025 | Completed: Period of performance ended Feb 3, 2025 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325412Pharmaceutical Preparation ManufacturingPrimarySmall business under this code’s size standard
- 424210Title not in the curated listSmall business under this code’s size standard
SAM.gov reports this entity as small under 2 of 2 NAICS codes. Size is determined per code (SBA size standards).
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with ACEY RX LLC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
